Evidence map›Paper›PMID 40377689›Full record

ReviewArchives of dermatological research2025

Mohs Micrographic Surgery (MMS) in immunosuppressed patients: a review of outcomes and prognosis.

Maira A Bhatty, Micah Belzberg, Allison T Vidimos, Christine Poblete-Lopez

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maira A BhattyCase Western Reserve University School of Medicine, Health Education Campus 9501 Euclid Ave, Cleveland, OH, 44106, USA. mab498@case.edu.
Micah BelzbergDepartment of Dermatology, Cleveland Clinic, Cleveland, OH, USA.
Allison T VidimosDepartment of Dermatology, Cleveland Clinic, Cleveland, OH, USA.
Christine Poblete-LopezDepartment of Dermatology, Cleveland Clinic, Cleveland, OH, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunosuppressed (IS) patients are at an increased risk of developing nonmelanoma skin cancers compared to immunocompetent (IC) patients. The standard of treatment in both cohorts is Mohs Micrographic Surgery (MMS); however, the impact and prognosis of MMS in IS patients has not been comprehensively characterized. This review elucidates post-MMS complications, recurrence, metastasis, and survival in IS patients with cutaneous malignancies. Results have important implications for pre-operative planning, and post-operative surveillance and management of IS patients with cutaneous malignancies.

Indexed as

Immunocompromised HostMohs SurgerySkin NeoplasmsHumansNeoplasm Recurrence, LocalPrognosisTreatment OutcomeImmunocompromisedImmunosuppressedMohsOrgan transplant

Identifiers

PMID40377689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.